Rhiannon N. Hardwick

1.
David M. Stresser, Anna K. Kopec, Philip Hewitt, et al. Towards in vitro models for reducing or replacing the use of animals in drug testing. Nature Biomedical Engineering. 2023:1-6. doi:10.1038/s41551-023-01154-7
View Full Reference
1.
Ivan Rusyn, Courtney Sakolish, Yuki Kato, et al. Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium. Toxicological Sciences: An Official Journal of the Society of Toxicology. 2022;188(2):143-152. doi:10.1093/toxsci/kfac061
View Full Reference
1.
Szczepan W. Baran, Paul C. Brown, Andreas R. Baudy, et al. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate). Alternatives to Animal Experimentation. 2022;39(2):297-314. doi:10.14573/altex.2112203
View Full Reference